Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis

Inflammation Research

Volumn 53, Issue 12, 2004, Pages 670-679

  Chen, J ^a   Zhang, X M ^a   Xu, Q ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Bone cell damage; Collagen induced arthritis; Cytokines; MMP; Spleen cells

Indexed keywords

CD4 ANTIGEN; COLLAGEN TYPE 2; CYCLOSPORIN; GAMMA INTERFERON; GELATINASE B; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; ARTICLE; BONE CELL; BONE INJURY; CELL POPULATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; IN VITRO STUDY; INFLAMMATORY CELL; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TH1 CELL; ZYMOGRAPHY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; CELLS, CULTURED; CHICKENS; COLLAGEN TYPE II; INTERFERON TYPE II; MALE; MATRIX METALLOPROTEINASE 9; MICE; NITRIC OXIDE; SPLEEN; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 12944299802     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1311-z     Document Type: Article

References (58)

1. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358: 903-11.
2. Lie JT. Vasculitis unlimited in rheumatoid arthritis: an illustrated review. Cardiovasc Pathol 1998; 7: 191-204.
3. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol 2002; 85: 89-99.
4. DeMaria AN. Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 2002; 89 (suppl): 33D-8D.
5. Bacon PA, Stevens RJ, Carruthers DM, Yong SP, Kitas GD. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002; 338-47.
6. Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2002; 2: 527-35.
7. Yamamura Y, Shelden E, Fox DA. Interactions between T cells and synovial fibroblasts. Mod Rheumatol 2000; 10: 16-8.
8. Sfikakis PP, Mavrikakis M. Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseases. Clin Rheumatol 1999; 18: 317-27.
9. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth F Rev 2002; 13: 357-68.
10. Kurowska M, Rudnicka W, Kontny E, Janicka I, Chorazy M, Kowalczewski J et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol. 2002; 169: 1760-7.
11. Hirayama T, Danks L, Sabokbar A, Athanasou NA. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 2002; 41: 1232-9.
12. Kanbe K, Takagishi K, Chen Q. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum. 2002; 46: 130-7.
13. Firestein GS. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Invest 1999; 103: 3-4.
14. El Desoky, Ehab S. Pharmacotherapy of rheumatoid arthritis: an overview. Curr Ther Res 2001; 62: 92-112.
15. Feldmann M, Maini RN. Anti-TNF-α therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163-96.
16. Kohsaka H. Gene therapy for arthritis. Mod Rheumatol 2000; 10: 78-82.
17. Li P, Schwarz EM. The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin Immunopathol 2003; 25: 19-23.
18. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-KappaB transcription factors in articular chondrocytes. Exp Cell Res 2003; 288: 208-17.
19. Iwakura Y. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth F Rev 2002; 13: 341-55.
20. Van Bezooijen RL, Van Der Wee-Pals L, Papapoulos SE, Lowik CW. Interleukin 17 synergises with tumor necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis 2002; 61: 870-76.
21. Horowitz MC, Xi Y, Wilson K, Kacena MA. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth F Rev 2001; 12: 9-18.
22. Holmdahl R, Bockermann R, Backlund J, Yamada H. The molecular pathogenesis of collagen-induced arthritis in mice - a model for rheumatoid arthritis. Ageing Res Rev 2002; 1: 135-47.
23. Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci 1997; 61: 1861-78.
24. Dayer JM. Interleukin-18, rheumatoid arthritis, and tissue destruction. J Clin Invest 1999; 104: 1337-9.
25. Verhoef CM, van Roon JA, Lafeber FP, Bijlsma JW. T1/T2 cell balance in rheumatoid arthritis. Clin Appl Immunol Rev 2001; 1: 153-61.
26. Parks E, Strieter RM, Lukacs NW, Gauldie J, Hitt M, Graham FL et al. Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis. J Immunol 1998; 160: 4615-9.
27. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-54.
28. Xu Q, Cao J, Wu F, Hayakawa Y, Saiki I, Koda A. Role of Th1 and Th2 cytokines in regulating the liver injury induced by delayed-type hypersensitivity to picryl chloride. Liver 1999; 19: 473-80.
29. Bellows CG, Ciaccia A, Heersche JN. Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differ in their response to corticosterone, cortisol and cortisone. Bone 1998; 23: 119-25.
30. van Goor H, Gerrits PO, Hardonk MJ. Enzyme histochemical demonstration of alkaline phosphatase activity in plastic-embedded tissues using a Gomori-based cerium-DAB technique. J Histochem Cytochem 1989; 37: 399-403.
31. Bai XC, Lu D, Bai J, Zhang H, Ke ZY, Li XM et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kB. Biochem Biophys Res Commun 2004; 314: 197-207.
32. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 1991; 142: 257-65.
33. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 1994; 174: 311-20.
34. Bounous DI, Campagnoli RP, Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis. 1992; 36: 1022-7.
35. Kim YM, Son K. A nitric oxide production bioassay for interferon-γ. J Immunol Methods 1996; 198: 203-9.
36. Chang NS, Carey G, Pratt N, Chu E, Ou M. P53 overexpression and downregulation of inter-α-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts. Cancer Lett 1998; 131: 45-54.
37. Spence SE, Lohrey NC, Ortiz M, Gooya J, Keller JR. Detection of growth factor receptor RNA in individual hematopoietic cells by in situ RT-PCR; comparison with RT-PCR. J Immunol Methods 2001; 257: 123-36
38. Baragi VM, Shaw BJ, Renkiewicz RR, Kuipers PJ, Welgus HG, Mathrubutham M et al. A versatile assay for gelatinases using succinylated gelatin. Matrix Biol 2000; 19: 267-73.
39. Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998; 76: 275-88.
40. Wu X, Wang C, Katoh H, Xing R, Zhang X, Yao G et al. Genetic profile of LIBP/1 inbred strain derived from the Kunming outbred stock of the mouse. Jikken Dobutsu 1992; 41: 541-3.
41. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100: 655-69.
42. Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002; 195: 1129-43.
43. Weigmann B, Neurath MF. T-bet as a possible therapeutic target in autoimmune disease. Expert Opin Ther Targets. 2002; 6: 619-22.
44. Ogawa Y, Kuwahara H, Kimura T, Tani Y, Yonehara S, Shiraishi A et al. Therapeutic effect of anti-Fas antibody on a collagen induced arthritis model. J Rheumatol 2001; 28: 950-5.
45. Seemayer CA, Kuchen S, Kuenzler P, Rihoskova V, Rethage J, Aicher WK et al. Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 2003; 162: 1549-57.
46. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002; 61(Suppl): 84-6.
47. Goldring SR. pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology 2003; 42 (suppl): ii11-6.
48. Haugeberg G, Orstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 2003; 15: 469-75.
49. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001; 44: 585-94.
50. Jasin HE. Mechanisms of joint destruction in rheumatoid arthritis. J Orthop Sci 2000; 5: 178-81.
51. Okada Y. Matrix-degrading metalloproteinases and their roles in joint destruction. Mod Rheumatol 2000; 10: 121-8.
52. Hansson GK, Lagerstedt E, Bengtsson A, Heideman M. IgG binding to cytoskeletal intermediate filaments activates the complement cascade. Exp Cell Res 1987; 170: 338-50.
53. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001; 44: 1003-12.
54. Takayanagi H, Oda H, Yamamoto S, Kawaguchi H, Tanaka S, Nishikawa T et al. A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 1997; 240: 279-86.
55. Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA et al. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 1995; 182: 449-57.
56. Cork BA, Tuckerman EM, Li TC, Laird SM. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6, LIF on the production of MMP and cytokines by human endometrial cells in vitro. Mol Hum Reprod 2002; 8: 841-8.
57. Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol 1999; 90: 65-78.
58. Han YP, Nien YD, Garner WL. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 2002; 277: 27319-27.